FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

E Oravcova

Research Profile

Disorders

Geographic Areas

Slovakia

Concepts & Ideas

Physiology

Microbial Drug Resistance

Procedures

Drug Therapy, Combination

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Michal Mego; L Ebringer; L Drgona; J Mardiak; Jan Trupl; R Greksak; I Nemova; E Oravcova; Vladimír Zajac; I Koza
Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Pilot study phase I.
Vladimir Krcméry; E Oravcova; Stanislav Spanik; M Mrazova-Studena; Jan Trupl; A Kunova; K Stopkova-Grey; Eva Kukuckova; Iveta Krupova; Andrea Demitrovicova; K Kralovicova
Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome.
Stanislav Spanik; Jan Trupl; A Kunova; L Drgona; T Salek; J Mardiak; Eva Kukuckova; M Studena; P Pichna; E Oravcova; Eva Grey; Pavol Koren; J Svec; J Lacka; J Sufliarsky; Vladimir Krcméry
Risk factors, aetiology, therapy and outcome in 123 episodes of breakthrough bacteraemia and fungaemia during antimicrobial prophylaxis and therapy in cancer patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of E Oravcova (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2005: Michal Mego; L Ebringer; L Drgona; J Mardiak; Jan Trupl; R Greksak; I Nemova; E Oravcova; Vladimír Zajac; I Koza
Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Pilot study phase I.
Neoplasma 2005;52(2):159-64.
1998: Vladimir Krcméry; E Oravcova; Stanislav Spanik; M Mrazova-Studena; Jan Trupl; A Kunova; K Stopkova-Grey; Eva Kukuckova; Iveta Krupova; Andrea Demitrovicova; K Kralovicova
Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome.
The Journal of antimicrobial chemotherapy 1998;41(3):373-80.
1997: Stanislav Spanik; Jan Trupl; A Kunova; L Drgona; T Salek; J Mardiak; Eva Kukuckova; M Studena; P Pichna; E Oravcova; Eva Grey; Pavol Koren; J Svec; J Lacka; J Sufliarsky; Vladimir Krcméry
Risk factors, aetiology, therapy and outcome in 123 episodes of breakthrough bacteraemia and fungaemia during antimicrobial prophylaxis and therapy in cancer patients.
Journal of medical microbiology 1997;46(6):517-23.
1997: K Kralovicova; Stanislav Spanik; E Oravcova; Marianna Mrazova; E Morova; V Gulikova; Eva Kukuckova; Pavol Koren; P Pichna; J Nogova; A Kunova; Jan Trupl; Vladimir Krcméry
Fungemia in cancer patients undergoing chemotherapy versus surgery: risk factors, etiology and outcome.
Scandinavian journal of infectious diseases 1997;29(3):301-4.
1997: Stanislav Spanik; Jan Trupl; A Kunova; R Botek; D Sorkovska; Eva Grey; M Studena; J Lacka; E Oravcova; A Krchnakova; Viera Rusnakova; J Svec; Iveta Krupova; Silvia Grausova; K Stopkova; Pavol Koren; Vladimir Krcméry
Viridans streptococcal bacteraemia due to penicillin-resistant and penicillin-sensitive streptococci: analysis of risk factors and outcome in 60 patients from a single cancer centre before and after penicillin is used for prophylaxis.
Scandinavian journal of infectious diseases 1997;29(3):245-9.
1996: Eva Kukuckova; Stanislav Spanik; I Ilavska; L Helpianska; E Oravcova; J Lacka; Iveta Krupova; Silvia Grausova; Pavol Koren; I Bezakova; Eva Grey; M Balaz; M Studena; A Kunova; K Torfs; Jan Trupl; S Korec; K Stopkova; Vladimir Krcméry
Staphylococcal bacteremia in cancer patients: risk factors and outcome in 134 episodes prior to and after introduction of quinolones into infection prevention in neutropenia.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1996;4(6):427-34.
1996: Stanislav Spanik; Jan Trupl; I Ilavska; L Helpianska; L Drgona; Andrea Demitrovicova; Eva Kukuckova; M Studena; P Pichna; E Oravcova; Viera Rusnakova; Pavol Koren; J Lacka; Vladimir Krcméry
Bacteremia and fungemia occurring during antimicrobial prophylaxis with ofloxacin in cancer patients: risk factors, etiology and outcome.
Journal of chemotherapy (Florence, Italy) 1996;8(5):387-93.
1996: Vladimir Krcméry; P Pichna; E Oravcova; J Lacka; Eva Kukuckova; M Studena; Silvia Grausova; K Stopkova; Iveta Krupova
Stenotrophomonas maltophilia bacteraemia in cancer patients: report on 31 cases.
The Journal of hospital infection 1996;34(1):75-7.
1996: E Oravcova; J Lacka; L Drgona; M Studena; L Sevcikova; Stanislav Spanik; J Svec; Eva Kukuckova; Eva Grey; J Silva; Vladimir Krcméry
Funguria in cancer patients: analysis of risk factors, clinical presentation and outcome in 50 patients.
Infection 1996;24(4):319-23.
1996: Vladimir Krcméry; J Trupl; L Drgona; J Lacka; Eva Kukuckova; E Oravcova
Nosocomial bacteremia due to vancomycin-resistant Staphylococcus epidermidis in four patients with cancer, neutropenia, and previous treatment with vancomycin.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1996;15(3):259-61.
1996: J Lacka; E Oravcova; L Sevcikova; M Studena; V Bachanova; Eva Kukuckova; Stanislav Spanik; J Sufliarsky; L Helpianska; Jan Trupl; A Kunova; I Vochyanova; Z Sycova; Eva Grey; Vladimir Krcméry
Vancomycin plus imipenem ceftazidime or ciprofloxacin in second line therapy in patients with febrile neutropenia not responding to first line therapy.
Chemotherapy 1996;42(2):146-9.
1996: Vladimir Krcméry; J Trup; A Kunova; Stanislav Spanik; L Drgona; E Oravcova; M Studena; J Lacka; L Sevcikova; Pavol Koren; Eva Kukuckova; K Stopkova; Iveta Krupova; Silvia Grausova; J Svec
Imipenen-resistant Ps. aeruginosa bacteraemia in cancer patients: risk factors, clinical features and outcome.
International journal of clinical pharmacology research 1996;16(2-3):43-9.
1995: V Studena; Z Sycova; L Helpianska; D Sorkovska; P Pichna; J Lacka; E Hlavacova; E Oravcova; Vladimir Krcméry; M Studena
Fluconazole versus itraconazole in therapy of oropharyngeal candidiasis in cancer patients: a prospective comparative randomized trial.
Journal of chemotherapy (Florence, Italy) 1995;7 Suppl 4():204-5.